The completion of the Diet and Biomarkers Survey in India (DABS-I) six months ago has sparked widespread confusion and concern over the lack of transparency regarding its anaemia prevalence data. Launched in December 2022, DABS-I was touted as a more scientific approach to understanding anaemia in the country, given the decision to drop it from the sixth National Family Health survey in 2023. The survey was completed in November 2025, but the much-awaited anaemia prevalence data remains under wraps, leaving experts and policymakers in the dark about the true extent of the issue.
Background and Context
India has long struggled with the burden of anaemia, a condition that affects nearly 70% of women and 50% of men in the country. The prevalence of anaemia is particularly high in rural areas, where access to nutritious food and healthcare is limited. The decision to drop anaemia from the sixth National Family Health survey was made with the intention of conducting a more comprehensive study through DABS-I. However, the delay in releasing the data has raised concerns about the government’s commitment to addressing this critical public health issue.
The DABS-I survey was designed to provide a more detailed understanding of the relationship between diet, biomarkers, and anaemia. The study aimed to collect data on a wide range of factors, including nutrient intake, haemoglobin levels, and anthropometric measurements. However, the delay in releasing the anaemia prevalence data has limited the utility of the study’s findings, making it difficult for policymakers to develop effective strategies to address the issue.
Consequences of Delayed Data Release
The continued delay in releasing the anaemia prevalence data has significant consequences for public health policy and programming. Without access to accurate and up-to-date data, policymakers are unable to make informed decisions about resource allocation and program development. This lack of transparency also undermines the credibility of the government’s commitment to addressing anaemia, ultimately harming the most vulnerable populations who rely on these programs for their well-being.
The delay in releasing the data also raises questions about the government’s priorities and the allocation of resources. With the country struggling to make progress on several public health fronts, including maternal and child health, the continued silence on anaemia prevalence is a worrying trend. The lack of transparency and accountability in data release undermines the trust between the government and its citizens, making it challenging to build partnerships and collaborations that are essential for addressing complex public health issues.
Calling for Transparency and Accountability
The Indian government must take immediate action to address the delayed release of anaemia prevalence data from the DABS-I survey. The public has a right to access accurate and timely data, which is essential for informed decision-making and effective policy development. The government must prioritize transparency and accountability in data release, ensuring that the needs and concerns of citizens are at the forefront of its decision-making process.
As the country continues to grapple with the burden of anaemia, it is imperative that the government takes a proactive approach to addressing this critical public health issue. The release of the anaemia prevalence data from the DABS-I survey is long overdue, and its delay has significant consequences for public health policy and programming. The government must act swiftly to rectify this situation and ensure that the needs of citizens are met with transparency, accountability, and a commitment to public health.
The continued silence on anaemia prevalence is a missed opportunity for the government to demonstrate its commitment to public health and transparency. It is time for the government to take a proactive approach to addressing this critical issue and provide the public with the data they need to make informed decisions about their health and well-being.
